Access cutting-edge macular degeneration treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access macular degeneration specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related macular degeneration treatment provided free
The main objective of the study is evaluation of the safety and tolerability of RPESC-RPE-4W as therapy for dry AMD.
Sponsor: Luxa Biotechnology, LLC
Check if you qualify for this macular degeneration clinical trial in Beverly Hills, CA
If you're searching for macular degeneration treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.